• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number 10601
Medical Device Problem Codes Failure to Advance (2524); Material Deformation (2976)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/22/2021
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that stent damage occurred and the procedure was cancelled.The greater than 80% stenosed target lesion was located in the very tortuous and severely calcified ostial circumflex.A 3.00 x 12mm synergy ii drug-eluting stent was advanced for treatment.However, the device could not cross the lesion and it was observed that the mid part of the stent strut was deformed after trying to cross the calcified lesion.The device was removed from the patient's body.The procedure was cancelled.No patient complications were reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: synergy ii us mr 3.00 x 12mm stent delivery system was returned for analysis.A visual examination of the stent found stent damage.Stent struts in the mid-section were lifted from the crimped profile.The undamaged stent outer diameter was measured and the result was within max crimped stent profile measurement.The balloon cones were reviewed, and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual and microscopic examination of the bumper tip showed no signs of distal tip damage.A visual and tactile examination of the hypotube shaft found multiple kinks.A visual and tactile examination of the outer and mid-shaft section and a visual examination of the inner lumen found no issues along the shaft polymer extrusion.No other issues were identified during analysis.
 
Event or Problem Description
It was reported that stent damage occurred and the procedure was cancelled.The >80% stenosed target lesion was located in the very tortuous and severely calcified ostial circumflex.A 3.00 x 12mm synergy ii drug-eluting stent was advanced for treatment.However, the device could not cross the lesion and it was observed that the mid part of the stent strut was deformed after trying to cross the calcified lesion.The device was removed from the patient's body.The procedure was cancelled.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Common Device Name
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key12135612
Report Number2134265-2021-08701
Device Sequence Number19846596
Product Code NIQ
UDI-Device Identifier08714729840053
UDI-Public08714729840053
Combination Product (Y/N)Y
Initial Reporter StateAL
Initial Reporter CountryUS
PMA/510(K) Number
P150003
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/08/2022
Device Model Number10601
Device Catalogue Number10601
Device Lot Number0025729958
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/20/2021
Initial Date Received by Manufacturer 06/22/2021
Supplement Date Received by Manufacturer08/03/2021
Initial Report FDA Received Date07/08/2021
Supplement Report FDA Received Date08/10/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age61 YR
-
-